Kidney Transplant Rejection Market: Innovations & Key Players The kidney transplant rejection market is expanding through advancements in immunosuppressive therapies and personalized medicine approaches. Key players including Novartis, Pfizer, and CSL Behring are developing novel biologics, targeted immunosuppressants, and companion diagnostics to improve graft survival and reduce rejection rates. Emerging biomarkers and monitoring technologies are enabling more precise management of post-transplant care. View Market Analysis: https://www.delveinsight.com/infographics/kidney-transplant-rejection-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr